CAMTA1-DT

Across TCGA pan-cancer cohorts, CAMTA1-DT RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated CAMTA1-DT data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CAMTA1-DT RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CAMTA1-DT expression acts as an unfavorable survival marker, although some lineages such as KIRP and OV show a favorable association.

KIRC, KIRP, and ACC are the cancer types where CAMTA1-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	II,III,IV	0.423	0.624	<.001	147	view →
KIRP	DFS	Median	II,III,IV	0.928	0.161	<.001	88	view →
ACC	DFS	Tertile	All	0.215	0.682	<.001	73	view →
OV	DFS	Median	All	0.426	0.333	.004	66	view →
LUAD	OS	Median	III,IV	0.773	0.549	.002	34	view →
CESC	OS	Tertile	All	0.944	0.826	.003	34	view →
PAAD	OS	Quartile	All	0.745	0.421	.002	27	view →
READ	DFS	Quartile	II,III,IV	0.921	0.727	.028	19	view →
LUSC	OS	Tertile	All	0.462	0.320	.011	15	view →
ESCA	OS	Median	IV	0.698	0.222	.006	12	view →
UCEC	DFS	Median	All	0.868	0.924	.007	10	view →
THCA	DFS	Tertile	All	0.887	0.768	.017	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

CAMTA1-DT–KIRC (DFS)

Open the KIRC breakdown →